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NEW FINDINGS  
1. What is the central question of this study? 
To evaluate whether elevated sympathetic nerve activity (SNA) occurs before the onset of 
arterial hypertension in a rat renovascular model of hypertension, the two kidney one clip 
(2K-1C) Goldblatt model, and to determine possible mechanisms and origins. 
 
2. What is the main finding and its importance?  
Sympathetic activity (SNA) can be raised prior to the onset of hypertension by the 3rd week 
after renal artery clipping and this originates, in part, from enhanced respiratory modulation. 
Spinal circuits contribute to the elevation of SNA but only when after hypertension has 
developed. 
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ABSTRACT  
Our knowledge of mechanisms responsible for both the development and maintenance of 
hypertension remains incomplete in the Goldblatt model (two kidney one clip, 2K1C). We 
tested the hypothesis that elevated sympathetic nerve activity (SNA) occurs before the onset 
of hypertension in 2K1C rats considering the time course of increase in SNA in relation to 
the onset of the hypertension is determined. We used a decorticated in situ working heart-
brainstem preparation of male Wistar rats comprising: SHAM (n=7), three weeks post 2K1C, 
of which some were hypertensive (2K1C-H, n=6) and others normotensive (2K1C-N, n=9), 
as determined in vivo a priori. Perfusion pressure was higher in both 2K1C groups (2K1C-H: 
76  1; 2K1C-N: 74  3 vs SHAM: 60  2 mmHg, p< 0.05). The SNA was elevated 
significantly in both 2K-1C groups (2K1C-H: 47.7  6.1; 2K1C-N: 32.8  2.8 vs SHAM: 
20.5  2.5 V, p< 0.05) due to its increased respiratory modulation; the chemoreflex was 
augmented and baroreflex depressed. Pre-collicular transection reduced SNA in all groups 
(2K1C-H: -32.5  7.5, 2K1C-NH: -48  6.9 vs SHAM: -13.2  1%, p< 0.05). Subsequent 
medullary-spinal cord transection abolished SNA in both SHAM and 2K1C-N but only 
decreased it by 57 5.5% in 2K1C-H. Thus, SNA is raised prior to hypertension onset by the 
3rd week after renal artery clipping and this originates, in part, from its enhanced respiratory 
modulation. Spinal circuits contribute to the elevation of SNA in the 2K1C model but only 
when after hypertension has developed.  
Key words: Goldblatt model, hypertension, sympathetic nerve activity, respiratory 
modulation.  
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INTRODUCTION 
Renovascular hypertension is considered one of the most frequent causes of 
secondary hypertension. Its prevalence is estimated between 1-5% of the general population 
of hypertensives (Elliott, 2007). One of the most widely used models for the study of 
experimental hypertension has been proposed by Goldblatt (Goldblatt et al. 1934), which is 
renovascular hypertension induced by partial stenosis of a renal artery by implantation of a 
silver clip  and called 2 Kidneys – 1 Clip (2R1C) (Goldblatt et al. 1934; Edmunds et al. 1991; 
Melaragno & Fink, 1996). Studies have shown that several factors are involved in the 
pathogenesis of hypertension including an elevation of renin-angiotensin-aldosterone system 
(RAAS) activity in which the cascade of events begins with increased renin secretion from 
the clipped kidney leading to increases in circulating angiotensin II (Ang II), sodium 
retention, blood volume expansion,  increased peripheral arterial resistance and elevated 
activation of sympathetic nerve activity (SNA), all of which increase blood pressure (BP) 
(Plotw, 1983; Michell & Navar, 1995; Navar et al. 1998; Lerman et al. 2005). 
Several studies have suggested a role of elevated SNA in the development of 
hypertension in 2K1C rats. One possible explanation for sympathetic activation is the central 
action of Ang II circulating in the periventricular tissue of the anterior ventral region of the 
third ventricle (AV3V). Brody and Johnson (1980) demonstrated that the electrolytic lesion 
AV3V region prevents or abolishes hypertension 2K1C. In 1982, Katholi demonstrated that 
renal denervation of the ischemic kidney improves hypertension in animals 2K1C 
independent of the levels of circulating angiotensin II and excretion of water and sodium, 
indicating participation of renal nerves (afferent and efferent) in this model. Later, Faber & 
Brody (1983), reported increased sympathetic tone in this model of hypertension. McElroy & 
Zimmerman (1989) demonstrated an increase of 1-adrenergic receptors affinity in the 
arterial vasculature of clipped kidney (2K1C) 2 weeks after clipping. At six weeks, the 
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affinity of these receptors are found increased in both kidneys when compared to control 
animals, however, at 12 weeks there was no difference. Similar data were also found by 
Nakada et al. (1996), which showed increased SNA 4 weeks post-clipping animals. Finally, 
Johansson et al. (1999), also reported an increase in SNA in hypertensive humans with 
renovascular hypertension by using 2 independent techniques for examination of sympathetic 
outflow. Overall sympathetic outflow, as assessed from measurements of total body NE 
spillover, was increased 2-fold compared with healthy controls and correlated closely with 
muscle sympathetic nerve activity (MSNA), supporting the contention of an elevated state of 
efferent sympathetic traffic in renovascular hypertension. We reported that 6 weeks after 
renal artery clipping in rats, the 2K1C group showed a significant increase in renal SNA (and 
arterial pressure) when compared with the control group in urethane anaesthetized rats 
(Oliveira-Sales et al. 2008, Campos et al., 2015). Additionally, the increase in SNA in the 
2K1C model seems to have both a direct and indirect mechanism both operating via the 
RAAS; indirectly sympathetic activation produces greater release of renin (Miyajima et al. 
1991; Johansson et al. 1999; Head & Burke, 2004). Burke et al. (2010) found that chronic 
rilmenidine (an imidazoline and 2-adrenoceptor agonist) treatment not only normalized 
arterial pressure and reduced renal SNA, but that it also markedly reduced basal plasma renin 
activity. This suggests that rilmenidine is an effective antihypertensive therapy for 
renovascular hypertension. Furthermore, the sympathetic  component may also be involved in 
other mechanisms, such as increased sodium resorption (Dibona & Kopp, 1997). However, 
whether renal or autonomic dysfunction is the predominant contributor to systemic 
hypertension is still debated (Esler et al. 2010; Navar, 2010) and whether elevated SNA is a 
cause of high blood pressure in renovascular hypertension remains unknown and 
controversial. 
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Previously, we described the temporal profile of underlying cardiovascular autonomic 
changes that occur in the Goldblatt rat model of hypertension followed out to 6 weeks post-
clipping (Oliveira-Sales et al. 2014). The parameters analysed were power spectral density 
analysis of both arterial pressure and pulse interval, and spontaneous cardiac baroreceptor 
reflex gain in conscious freely-moving rats fitted with radio-telemetry devices. Our findings 
indicated that the 2K1C Goldblatt model is associated with an immediate loss of cardiac 
baroreflex sensitivity accompanied with an apparent withdrawal of cardiac vagal tone, and 
increase in neurohumoral control of arterial pressure. By around the fourth week post 
clipping there was a large increase in low frequency spectra of systolic blood pressure, 
indicative of an elevated sympathetic vasomotor drive, that accompanied the most steep 
development of the hypertension (Oliveira-Sales et al. 2014). This sympathetic hyperactivity 
was also observed when measured directly from the renal nerve in anesthetized animals 6 
weeks after clipping (Oliveira-Sales et al. 2008), suggesting that the maintenance phase of 
the hypertension was also dependent on high sympathetic drive. However, exactly when the 
increase in SNA was initiated relative to the onset of the hypertension could not be 
determined in our previous studies (Oliveira-Sales et al. 2010, 2014), as we were limited to 
the relatively insensitive and indirect measurement of SNA as inferred from power spectral 
analysis of systolic blood pressure. Moreover, the relative contributions of brainstem and 
spinal cord mechanisms in the generation of the increased SNA remain unknown.  
In the present study, our hypothesis was that SNA is elevated before the development 
of hypertension in the Goldblatt rat model and this is mediated, in part, by greater modulation 
from the central respiratory pattern generator; the latter mechanism has been seen in at least 
two other models of hypertension (Moraes et al. 2014; Simms et al. 2009; Zoccal et al. 
2008). Therefore, we analyzed cardiovascular autonomic function in the third week after 
renal artery clipping to assess its relationship with the onset of hypertension in both in vivo 
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and a non-anaesthetized decorticated in situ rat preparations. At this stage, blood pressure and 
sympathetic modulation of the cardiovascular system increases, however, it is not well 
established if the blood pressure increases before or after sympathetic overactivity (Oliveira-
Sales et al. 2014). 
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METHODS 
The authors have read, and the experiments comply with, the policies and regulations of 
Experimental Physiology given by Grundy (2015). 
 
Animals 
All procedures conformed to the UK Animals (Scientific Procedures) Act 1986 and were 
approved by the University of Bristol Ethical Review Committee (Personal Licence No. 
30/8202). Weaned juvenile male Wistar rats (n=22, 30g; Charles River Laboratories, UK) 
were housed individually, allowed normal rat chow and drinking water ad libitum, and kept 
on a 12-hour light/12-hour dark cycle.  
 
Experimental Protocol 
In the first day of the protocol the left kidney was clipped in juvenile rats and three weeks 
later, the systolic arterial pressure (SBP) was measured before making the working heart-
brainstem preparation (WHBP) by inserting an arterial catheter, in vivo under anesthesia 
(halothane). Once these data were acquired rats were decorticated to make insentient and 
perfused arterially. The perfusion pressure (PP), heart rate (HR), thoracic sympathetic nerve 
activity (tSNA) and phrenic nerve activity (PN) were measured during the basal conditions, 
peripheral chemoreceptor and baroreceptor reflexes were assessed, two sequential spinal 
transections were performed and the nerves were recorded as well. 
 
Goldblatt model of hypertension (two kidney one clip, 2K1C)  
The rats were anesthetized with ketamine (60 mg/kg) and medetomidine (250 g/kg) 
intramuscularly. The level of anaesthesia was checked frequently by testing limb withdrawal 
reflexes to noxious pinching and additional doses of 0.1 mL were administered (i.m.) as 
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required. The temperature of the rat was maintained at 37°C using a feedback controlled 
heating blanket. Via a midline laparotomy, the left renal artery was obstructed partially with a 
silver clip of 0.1 mm width. The SHAM animals were submitted to the same surgical 
procedure without clip placement and partial renal artery occlusion. Anesthesia was reversed 
with atipamezole (1 mg/kg). 
 
In vivo blood pressure recording 
Pulsatile arterial blood pressure was measured exactly 3 weeks after renal artery clipping via 
an arterial catheter in conscious rats. Rats, now weighing 60–90 g, were anaesthetized with 
halothane (3%) until loss of their paw withdrawal reflex and the femoral artery cannulated so 
that the catheter tip lay in the descending aorta. Blood pressure was measured 10 min after 
termination of anesthesia for 5 minutes when the animals remained sedated but not 
anesthetised. In all cases rats responded to a mild pinch of the tail or rear hind paw. This was 
done to ensure a similar behavioural state across all rats. The data were digitized using a 
CED 1401 A–D interface (CED, Cambridge Electronic Design, Cambridge, UK) and a 
computer running Spike 2 software (CED). 
 
In situ working heart–brainstem preparation (WHBP) 
After measuring arterial pressure, recordings of the thoracic sympathetic chain activity were 
performed as described previously (Paton, 1996; Antunes et al. 2006; Colombari et al. 2010). 
Briefly, rats were heparinized (1000 units, given i.p.) and subsequently re-anaesthetized 
deeply with halothane (5%) until loss of their paw withdrawal reflex. They were transected 
sub-diaphragmatically, immersed in carbogenated (95% O2 and 5% CO2) modified Ringer’s 
solution containing in mM: NaCl 120, NaHCO3 24, KCl 3, CaCl2 2.5, MgSO4 1.25, KH2PO4 
1.25, glucose 10; pH 7.3 at 10ºC, and decorticated, making them insentient. The phrenic 
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nerve was cut distally. Preparations were transferred to a recording chamber. The descending 
aorta was perfused via a double-lumen cannula (DLR-4, Braintree Scientific, MA, USA) at a 
flow rate of 21 ml/min of Ringer solution containing Ficoll (2.5%) and carbogen (95% O2, 
5% CO2) gassed at 32°C. The second lumen of the catheter monitored aortic perfusion 
pressure. Perfusion was supplied via a peristaltic roller pump (Watson Marlow 505D). 
Vasopressin was added to the perfusate to elevate perfusion pressure; an equivalent amount 
(400 pM) was used in all groups. The phrenic nerve and thoracic sympathetic chain (t; T8–
T10 spinal level) were recorded simultaneously via bipolar glass suction electrodes; neural 
signals were amplified and filtered (100 Hz-1.5 kHz and 50 Hz-1.5 kHz, respectively, 
Neurolog). Nerve recordings were rectified, integrated and smoothed (50 ms). To standardize 
the data across preparations, noise levels were removed from the raw signal by applying 
lidocaine (2%) to the sympathetic chain at the end of the experiment; the noise level was 
measured and subtracted digitally.  
 
Peripheral chemoreceptor and baroreceptor reflexes 
Peripheral chemoreceptors were stimulated using sodium cyanide (NaCN; 0.03%, 25, 50 and 
75μL bolus) injected into the aorta. The peripheral chemoreceptor reflex consisted of an 
increase in central respiratory drive, bradycardia, increased tSNA and a pressor response. The 
baroreflex was activated by perfusion pressure challenges (generated by altering the perfusate 
flow). Initial studies used flow steps to increase perfusion pressure (by 30 mmHg over 1 s) 
from a range of different baseline pressures (30–80 mmHg, by adjusting the baseline flow) 
comparable to that described previously (Paton & Kasparov, 1999).  
 
Brain transection in situ  
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Two sequential transections were performed using a scapel blade: (i) pre-collicular 
transection (to disconnect the hypothalamus) and (ii) medulla oblongata–spinal cord junction. 
Transections were confirmed histologically.  
 
Data Analysis 
Data were digitized using a CED 1401 A–D interface (CED, Cambridge Electronic Design, 
Cambridge, UK) and a computer running Spike 2 software (CED) with custom-written 
scripts for data acquisition and on- and off-line analyses. tSNA changes were expressed as 
absolute levels and peak amplitude. Phrenic-triggered averaging (30 consecutive cycles) of 
integrated tSNA was carried out off-line as per Simms et al. (2009) (Simms et al. 2009). 
The respiratory cycle was divided into inspiratory and expiratory periods to assess the area 
under the curve of tSNA during these phases. To analyse the peripheral chemoreceptors 
reflex the tSNA changes were expressed as percentage difference from baseline, peak 
amplitude and duration.  The time constant of 1 s was used to calculate the integrated SNA. 
From the dynamic biphasic pressure ramps (over 30 s) a baroreflex–function curve was 
constructed for SNA activity by fitting a logistic sigmoid (Prism5, Graphpad, CA, USA): y 
= P4 + P1/1 + exp(P2(x − P3)) where y =SNA, P1 =range; P2 =slope coefficient; P3 
=perfusion pressure at 50% (PP50%); P4 =minimum; x =perfusion pressure. The curves 
were fitted to integrated SNA (time constant of 1 s) averaged into 1 s bins (n =30), 
measured over the extent of the ramp. The peak baroreflex gain was calculated from the first 
derivative. 
Data presented are the mean ± Standard Error (S.E.M.). Data were compared using One-
way ANOVA followed by Newman Keuls’s for comparisons (statistical software Graphpad 
Prism 5.0). The level of statistical significance was defined as P < 0.05.  
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RESULTS 
In vivo measurements 
Arterial blood pressure and heart rate measured 3 weeks after renal artery clipping 
In 15 rats with a clipped renal artery, we observed after 3 weeks that just some animals (n = 
6) exhibited an increase in SBP (i.e. 184 ± 11 mmHg; P<0.0001). In the other 9 animals, SBP 
was 106 ± 3 mmHg and not different to SHAM controls (98 ± 3 mmHg) (Figure 1A). So, we 
separated rats into 3 groups: hypertensive 2K-1C rats (2K1C-H, n=6), normotensive 2K1C 
(2K1C-N, n=9) and SHAM (n=7). In all rat groups operated, we verified that the clip was 
securely on the renal artery with no notable difference in its position or orientation. A 
significant increase in the diastolic blood pressure (DBP) also occurred at 3 weeks post 
clipping in 2K1C-H versus both the SHAM and 2K1C-N groups (158  22 vs 70  4 vs 78  
4 mmHg, respectively; P<0.05; Figure 1B). The values of HR were unchanged in all groups 
(SHAM: 312  8; 2K1C-N: 302  6; 2K1C-H: 314  6 bpm), Figure 1C. 
 
In situ measurements 
Perfusion pressure 
Since flow rate and vasopressin used were similar in all three rat groups, differences in PP 
can be expected to reflect alterations in peripheral vascular resistance directly. The PP was 
significantly higher in both 2K1C groups (2K1C-H: 76  0.4 mmHg; 2K1C-N: 74  3.0 
mmHg) versus SHAM (62  3 mmHg, P<0.05, Figure 1D). 
 
Sympathetic activity is raised 3 weeks after renal artery clipping independent of the 
hypertension and has increased respiratory modulation in situ 
Figure 2A shows representative recordings from a SHAM, 2K1C-N and 2K1C-H rats 
indicating elevated perfusion pressure in the 2K1C-N rat and further elevated in 2K1C-H rat 
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compared to SHAM indicative of increased peripheral vascular resistance in the 2K1C 
groups. 
 
An elevation in tSNA preceded the hypertension recorded in vivo in the Goldblatt model. 
However, there were qualitative differences between hypertensive and normotensive 2K1C 
groups. tSNA was significantly raised in both 2K1C groups relative to SHAM (2K1C-H: 
21.7  0.3 vs SHAM: 4.5  0.7 μV, P<0.05, 2K1C-N: 13.8  1.2 vs. SHAM, P<0.05, Figure 
3A). As shown in Figure 3A, the tSNA was higher in the hypertensive 2K1C-H (i.e. 21.7  
0.3 vs 2K1C-N: 13.8  1.2, P<0.05). Correspondingly, both 2K1C groups exhibited a higher 
peak burst amplitude than the SHAM group (2K1C-H: 47.7  6.1; 2K1C-N: 32.8  5.6 vs 
SHAM: 20.5  02.5 μV, P<0.05, Figure 3B). tSNA showed clear respiratory modulation with 
peak activity coincident at the end of inspiration and start of expiration in all three rat groups 
(Figure 2B). However, the respiratory modulation of tSNA was increased in both Goldblatt 
rat groups. For example, there was a significant increase in the area under the curve of tSNA 
during inspiration in both 2K1C rat groups relative to SHAM and the hypertensive Goldblatt 
group showed greater modulation compared to the normotensive 2K1C group too: 
(Inspiratory modulation: 2K1C-H: 24.2  2.1 vs. 2K1C-N: 14.7  1.2 μV.s, P<0.05; 2K1C-H 
vs SHAM: 9.5  1.4 μV.s-1, P<0.05 and 2K1C-N vs SHAM, P<0.05). Differences during 
early expiration were also exaggerated (Expiratory modulation: 2K1C-H: 52.9  1.8 vs. 
2K1C-N: 34.5  1.0 μV.s-1, P<0.05; 2K1C-H and 2K-1C-N vs. SHAM: 20.4  1.3 μV.s-1, 
P<0.05, Figure 3C). 
 
Phrenic Nerve Motor Output in Goldblatt rats 
The frequency of phrenic nerve discharge was unchanged in all groups (2K1C-H: 21.9  3.3; 
2K1C-N: 15.4  1.3 vs SHAM: 19.7  0.9 bursts per min, Figure 3D). Additionally, 
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inspiratory time did not differ significantly among groups (2K1C-H: 0.7  0.02; 2K1C-N: 1.0 
 0.1; SHAM: 0.9  0.03 s), and expiratory time was unchanged too (2K1C-N: 3.0  0.2 vs 
SHAM: 2.2  0.1 sec P<0.05, Figure 3F). In contrast, the peak amplitude of phrenic activity 
was lower in hypertensive animals (2K1C-H: 6.1  0.5; 2K1C-N: 8.5  0.7; SHAM: 12.6  
2.5 μV, Figure 3E).  
 
Peripheral chemoreceptor and arterial baroreceptor reflexes 
Figure 4A,B,C shows the representative recordings of the peripheral chemoreceptor reflex in 
SHAM, 2K1C-N and 2K1C-H rats. The chemoreflex evoked increased the percentage 
difference from baseline and duration of SNA in the 2K1C rat groups compared to SHAM 
(P<0.05, Figure 4D,E). However, the chemoreflex induced change in peak amplitude of SNA 
and bradycardia did not differ among the three rat groups (Figure 4F and 4G), only 2K1C-H 
vs. SHAM at 75uL showed a tendency of different statistically (p=0.08). 
Figure 5A shows representative recordings from SHAM, 2K1C-N and 2K1C-H rats during 
baroreflex testing. Logistic sigmoid baroreflex function curves were fitted to the integrated 
sympathetic and HR data and showed an impaired baroreflex in the hypertensive animals 
(Figure 5B). The sympathetic gain decreased in the 2K1C-H and 2K-1C-N groups when 
compared to the SHAM group (2K1C-H:0.05  0.01; 2K1C-N: 0.23  0.1 and SHAM:0.45  
0.11 μV.mmHg-1); the difference between 2K1C-H vs SHAM was significant (p<0.05). In 
addition, the cardiac baroreflex gain was reduced in both 2K1C groups compared to the SHAM 
group (2K1C-H:-0.04  0.009; 2K1C-N: -0.06  0.02 and SHAM:-0.47  0.1 bpm.mmHg-1; 
2K1C-H vs. SHAM, p<0.05) (Figure 5C) .  
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Neural Circuits Involved in Generating Sympathetic Activity in Goldblatt rats  
Pre-collicular transection reduced tSNA in all rat groups (2K1C-H: -32.5  7.5; 2K1C-N: -
48.0  6.9 vs SHAM: -13.2  1.0 % P<0.05). A subsequent transection at the medullary-
spinal cord junction abolished tSNA in both SHAM and 2K1C-N groups. In contrast, tSNA 
in 2K1C-H rats was not completely abolished (-57.5  5.5%, P<0.05, Figure 6A). Figure 4B 
shows a representative example of baseline sympathetic activity of SHAM, 2K1C-N and 
2K1C-H rats. At the end of the experiment, we compared tSNA levels to those observed after 
lidocaine applied to the sympathetic chain (Figure 6B). 
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DISCUSSION 
The three major new findings of this study are: (i) on the 3rd week after clipping the 
renal artery, SNA is raised relative to SHAM operated animals which can either occur prior 
to the onset of hypertension or accompany it; (ii) the increased SNA is generated, in part, 
from enhanced respiratory modulation during late inspiratory and early expiratory phases; 
(iii) in hypertensive Goldblatt rats ~40% of sympathetic activity remains after dis-connecting 
the spinal cord from the brainstem. 
Our aim was to determine when SNA increased relative to the onset of hypertension 
in the Goldblatt rat model. Based on our previous spectral density analysis of systolic blood 
pressure, we detected an increase in SNA around the fourth week post-clipping in conscious, 
radio-telemetered rats, a time coincident with the mid-point rise in arterial pressure (Oliveira-
Sales et al. 2014). .Herein, we studied rats exactly three weeks post-clipping, a time closer to 
the initiation point of the rise in arterial pressure, which occurred between the second and 
third week post-clipping (Oliveira-Sales et al. 2014). In 15 rats with a clipped renal artery, 6 
were hypertensive and 9 normotensive relative to SHAM operated animals three weeks after 
clipping. Given that there was no obvious difference between rats that were hypertensive 
versus normotensive in terms of both the clip position/orientation and degree of sedation 
post-anaesthesia (see Methods), our interpretation is that three weeks post-clipping reflects 
the approximate time threshold for the elevation of blood pressure. However, we didn’t 
measure levels of circulating angiotensin. In fact, we believe that those animals that were 
clipped and did not show hypertension may well go on to develop hypertension. 
We believe the WHBP  is more physiological than an anaesthetised preparation, 
which the bulk of relevant literature is based on. Importantly, we have measured brain tissue 
oxygen and CO2 and pH (Wilson et al. 2001) and when these are within physiological limits 
eupneic breathing is generated (St-John & Paton, 2003). This has been critical in ensuring 
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real time monitoring of the physiological viability of our preparation. Our lab has recorded 
sympathetic activity from conscious rats previously (McBryde et al. 2013) and this activity 
shows both baroreflex and respiratory modulated discharge, as we find in the in situ rat 
preparation (present study).  The in situ preparation has shown nicely that the baroreflex is 
pressure threshold dependent as known in vivo and re-set in hypertension as seen in vivo and 
humans (Simms et al. 2007). The carotid chemoreflex evoked sympathetic activity is 
heightened in hypertension as reported in vivo (McBryde et al. 2013, Tan et al. 2010) and 
humans (Somers et al. 1988). Numerous studies of ours have shown that the activity in the 
preparation is dependent on drives from hypothalamus and RVLM as seen in vivo 
(Colombari et al. 2010; Oliveira-sales et al. 2010). The hypothalamic PVN responds to 
hyperosmolarity to increase sympathetic activity (Antunes et al. 2006). These are just some 
of the comparable data that support our contention that the WHBP model is usefully 
physiological. Most recent studies on chemoreflex in hypertension have translated directly 
across to conscious rats. 
 
SNA elevation is independent of hypertension at onset of Goldblatt hypertension 
In our in situ studies there was a significant elevation in SNA in all renal artery 
clipped rats relative to SHAM rats that was highest in those animals that had already 
developed hypertension. This leads to two deductions: first, SNA can be elevated ahead of 
Goldblatt hypertension. This finding supports the notion of a causative role of sympathetic 
activity in the initiation as well as the development and maintenance of the high blood 
pressure (Oliveira-Sales et al. 2014) and is consistent with data from the spontaneously 
hypertensive rat (Simms et al. 2009; Zoccal et al. 2008) and humans (Grassi, 2004a e 2004b; 
Smith et al. 2002; 2004). A further study will be needed to assess exactly when the SNA first 
shows elevated levels post-renal artery clipping. Second, the finding that SNA was higher in 
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the 2K1C-H than the 2K1C-N rat group suggests that substantial levels of activity are needed 
to generate a rise in arterial pressure. If not contributing to high blood pressure this raises the 
issue as to the functional importance of the raised SNA in the 2K1C-N rat. In our in situ 
studies the latter group did show an elevated perfusion pressure relative to SHAM (and not 
different to 2K-1C-H group) suggesting that vascular resistance was already elevated, 
perhaps due to sympathetically mediated re-modelling/stiffening. This finding is of interest 
because in vivo, no hypertension was recorded in the 2K1C-N group. Reasons for this may 
include differences in: (i) cardiac output; (ii) circulating plasma levels of renin and 
angiotensin II; (iii) noradrenaline and/or co-transmitter released; (iv) sensitivity of receptors 
in the smooth muscle end-plate (McElroy & Zimmerman, 1989). An additional possibility is 
that the baroreceptor reflex was less attenuated in the 2K1C-N relative to 2K1C-H rats 
thereby capable of maintaining pressure within normal levels. The data in Figure 6 shows 
that whilst the baroreflex is partially attenuated compared to SHAM controls, both its 
sympathetic and cardiac limbs remain fully functional, which is not the case in 2K1C-H rats. 
It is clear from previous studies that angiotensin II (peripheral and/or central), which 
becomes elevated in the Goldblatt model, can attenuate baroreflex function (Polson et al. 
2007; Tan et al. 2007; Kasparov et al. 1998; Paton & Kasparov, 1999) this mechanism could 
explain the data we report herein. 
 
Novel mechanisms driving SNA in Goldblatt model of hypertension 
There are likely to be multiple mechanisms involved in increasing SNA in the Goldblatt 
model and these are likely to change with time as the pathology matures. For example, many 
studies have demonstrated the role of renal afferents (Katholi et al. 1982; Campese et al. 
2004), neurohumoral activation including elevated renin and angiotensin II activity for 
increasing SNA following clipping of a renal artery (Oliveira-Sales et al. 2014). There is also 
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evidence for angiotensin II acting both via the circumventricular organs (to activate the 
subfornical organ) and via area postrema to modulate the other downstream cardiovascular 
control regions of the brain, such as nucleus of the solitary tract, paraventricular nucleus of 
the hypothalamus and rostral ventrolateral medulla resulting in elevated SNA and BP (Ku et 
al. 1999; Ferguson 2009; de Oliveira-Sales et al. 2010; Nishi et al. 2013; Biancardi et al. 
2014). Certainly the present finding of a reduction in SNA after pre-collicular transection is 
consistent with excitatory drives from the diencephalon. However, in the in situ preparation 
there are no kidneys nor circulating renin or angiotensin II yet SNA remains elevated. This 
observation indicates that the role of renal afferents or forebrain structures is not necessarily 
important for the maintenance of high SNA post renal artery clipping (at least for several 
hours while the preparation remains viable). However, renal afferents and angiotensin II may 
play major roles in triggering the change in the central set point of SNA and its baroreflex 
control through long lasting mechanisms such as change in gene expression (Johnson et al. 
2015).  
Previously, we demonstrated a vital role for the rostral ventrolateral medulla in 
elevating arterial pressure in the Goldblatt rat and that this was entirely dependent upon a 
local increase in reactive oxygen species (Oliveira-Sales et al. 2008, 2010). In the 
normotensive 2K1C rat group, disconnection of the spinal cord from the medulla oblongata 
abolished all SNA suggesting a dependence on medullary sites such as the rostral 
ventrolateral medulla. In contrast, in the 2K1C-H rat, dis-connection of the medulla from the 
spinal cord did not abolish SNA; our data indicated that at least 40% of SNA could be 
maintained by neural circuitry in the spinal cord in the 2K1C-H group. How spinal circuitry 
is recruited in the 2K1C-H but not 2K1C-N group is not clear but may relate to the absolute 
level of SNA and an elevated intrinsic excitability of pre- and post- ganglionic sympathetic 
neurones. This could come about through sympathetic and /or angiotensin II mediated 
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activation of the immune system affecting neurones within both the spinal cord and 
sympathetic chain (Marvar et al. 2010; Zubcevic et al. 2011; Zubcevic et al. 2014). 
 Given the recent interest in the carotid body and hypertension (Ratcliffe et al. 2014; 
McBryde et al. 2013; Tan et al. 2010; Peng, et al. 2014) we postulate that in the 2K1C rat 
groups the carotid bodies become sensitized, which is generally supported by our findings 
(Figure 5). In the spontaneously hypertensive rat, the carotid body generates aberrant 
discharge, which drives sympathetic nerve activity. Preliminary data suggest that carotid 
body resection stunts the development of hypertension in the Goldblatt rat (W. Pijacka and 
J.F.R. Paton – unpublished data). Why the peripheral chemoreceptors become activated in 
renovascular hypertension is unknown but could occur because of raised sympathetically 
mediated vasoconstriction in the carotid body itself, activation of glomus cells by angiotensin 
II (Allen, 1998; Lam & Leung, 2008) or local/systemic inflammation (Ackland et al. 2013).  
  
Renal denervation as an anti-hypertensive strategy in renovascular hypertension 
Radio frequency ablation of renal nerves has been used to interrupt both afferents from and 
sympathetic innervation to the kidney as an interventional anti-hypertensive therapy in drug-
resistant hypertensive patients (Krum  et al. 2014). Given the inability to select patient 
responders (Mahfoud et al. 2014; Persu et al. 2014; Barnes et al. 2014) it has been suggested 
to consider patients with renovascular or chronic kidney disease related hypertension 
(Papademetriou et al. 2014). However, based on our findings caution should be aired since 
SNA persisted in the absence of both renal nerves and the kidneys albeit only for several 
hours during the viability of the preparation.  Nevertheless, the observation that a 
pathological condition can persist in the absence of the triggering mechanism is currently 
most pertinent and should be considered in any interventional approach. Moreover, 
elucidation of increased ‘layers’ of neural circuitry (diencephalon, pons-medulla and spinal 
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cord) that become recruited as hypertension develops in renovascular hypertension informs 
that the target(s) may move and become increasingly more complex. 
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FIGURES LEGENDS 
 
Figure 1. Cardiovascular parameters measured in SHAM and 2 Kidney-1Clip (2K-1C) rats 
in vivo. [A] Systolic blood pressure (SBP), [B] diastolic blood pressure (DBP) and [C] heart 
rate (HR) measured before the experimental protocol by the direct method via an arterial 
catheter. *P<0.05 different from SHAM group; † P<0.05 different from Normotensive 2K1C 
(One-way ANOVA followed by the Newman Keuls’s post-test). [D] Perfusion pressure (PP) 
measured during the in situ working heart brainstem preparation of SHAM rats (n = 7) and 
2K1C (3 weeks) of which some were hypertensive (2K1C-H, n = 6) or and others 
normotensive (2K1C-N, n = 9). PP was measured at same perfusion flow rates in all 3 
groups. Values are expressed as the means ± SEM.  
 
Figure 2. In situ sympathetic activity 3 weeks after renal clipping. [A] Representative 
recordings from SHAM, normotensive 2 Kidney-1Clip (2K1C-N) and hypertensive 2 
Kidney-1Clip (2K1C-H) rat, showing basal values in integrated thoracic sympathetic nerve 
activity (tSNA), frequency of tSNA, integrated phrenic nerve (PN), heart rate (HR) and 
perfusion pressure (PP). [B] Representative phrenic nerve cycle-triggered averages (CTA) of 
sympathetic nerve (SN) activity in SHAM, 2K1C-H and 2K1C-N groups. Each CTA panel 
comprises 30 PN cycles.  
 
Figure 3. Sympathetic activity is raised 3 weeks after renal artery clipping and shows 
increased respiratory modulation. [A] Graphs show thoracic sympathetic nerve activity 
(tSNA), [B] peak of amplitude of tSNA burst, [C] area of tSNA burst during inspiration and 
expiration, [D] phrenic nerve activity (PN), [E] peak of amplitude of PN burst and [F] 
duration of phrenic bursts (inspiration) and period between bursts (expiration). Values are 
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expressed as mean ± SEM. *P<0.05 different from SHAM group; † P<0.05 different from 
2K1C-N. (One-way ANOVA followed by the Newman Keuls’s post-test). 
 
Figure 4. The chemoreflex evoked increase in both amplitude and duration of SNA were 
both potentiated in the 2K1C rat groups compared to SHAM. Representative recordings from 
SHAM, 2K1C-N and 2K1C-H rat, showing values in integrated thoracic sympathetic nerve 
activity (tSNA), frequency of tSNA, frequency of phrenic nerve (PN), heart rate (HR) and 
perfusion pressure (PP) during infusion of 25 uL [A], 50 uL [B] and 75 uL of NaCN [C]. 
Mean percent changes from control sympathetic chain activity (tSNA) during chemoreflex 
activation induced by increasing doses of NaCN in SHAM, 2K1C-N and 2K1C-H [D]; 
Duration of responses [E]; Changes in peak amplitude of tSNA [F]; Changes in heart rate 
(HR) [G]. *P<0.05 different from SHAM group (One-way ANOVA followed by the 
Newman Keuls’s). 
 
Figure 5. The sympathetic gain decreased in the hypertensive 2 Kidney-1Clip (2K1C-H) and 
normotensive 2 Kidney-1Clip (2K-1C-N) groups when compare to the SHAM group. [A] 
Representative recordings from SHAM, 2K1C-N and 2K1C-H rat, showing values in 
integrated thoracic sympathetic nerve activity (tSNA), frequency of tSNA, heart rate (HR) 
and perfusion pressure (PP) during baroreflex. [B] Logistic sigmoid baroreflex function 
curves were fitted to the sympathetic and heart rate data from one representative rat of each 
group SHAM, 2K1C-N and 2K1C-H. [C] Sympathetic and cardiac gain of SHAM, 2K1C-N 
and 2K1C-H groups. *P<0.05 different from SHAM group (One-way ANOVA followed by 
the Newman Keuls’s post-test). 
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Figure 6. Pre-collicular transection reduced SNA in all rat groups. Subsequent transection at 
the medullary-spinal cord abolished SNA in SHAM and normotensive 2 Kidney-1Clip 
(2K1C-N) but not hypertensive 2 Kidney-1Clip (2K1C-H) rats. [A] Graph shows changes in 
tSNA after pre-collicular and medullary-spinal cord transections in SHAM (n=5), 2K1C-N 
(n=5) and 2K1C-H group (n=2). *P<0.05 different from SHAM group; † P<0.05 different 
from 2K1C-N (One-way ANOVA followed by the Newman Keuls’s post-test. [B] 
Representative recordings baseline values and effect of pre-collicular transection and 
subsequent medullary-spinal cord transection and following lidocaine on integrated thoracic 
sympathetic nerve activity (∫tSNA) and frequency of tSNA from SHAM, 2K1C-N and 2K1C-
H rats.  






